Table 4.
Influence of clinical variables on beta diversity.
| Clinical variable | r2 | P-value |
|---|---|---|
| Mode of delivery | 0.02 | 0.009* |
| Type of feeds (breast, bottle or mixed) | 0.006 | 0.264 |
| Homozygous p.Phe508Del | 0.02 | 0.004* |
| Pancreatic insufficiency | 0.009 | 0.06 |
| Gastro-oesophageal reflux disease | 0.005 | 0.215 |
| Upper respiratory tract symptoms (yes/no) | 0.01 | 0.027* |
| Lower respiratory tract symptoms (yes/no) | 0.004 | 0.327 |
| Any P. aeruginosa grown | 0.01 | 0.015* |
| Nebulised antibiotics | 0.01 | 0.039* |
| Oral antibiotics | 0.01 | 0.006* |
*Denotes clinical variables which exerted a significant influence (P < 0.05) on the Bray Curtis dissimilarity score as measured by permutational multivariate ANOVA (PERMANOVA).